Search

Your search keyword '"HELZLSOUER, KATHY J"' showing total 792 results
Start Over Author "HELZLSOUER, KATHY J"

Refine your results

more »

more »

more »

more »

more »
792 results on '"HELZLSOUER, KATHY J"'

1. Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers

Author

Ellison, Gary L, Helzlsouer, Kathy J, Rosenfield, Sonia M, Kim, Yun, Ashare, Rebecca L, Blaes, Anne H, Cullen, Jennifer, Doran, Neal, Ebbert, Jon O, Egan, Kathleen M, Heffner, Jaimee L, Lee, Richard T, McClure, Erin A, McDaniels-Davidson, Corinne, Meghani, Salimah H, Newcomb, Polly A, Nugent, Shannon, Hernandez-Ortega, Nicholas, Salz, Talya, Vidot, Denise C, Worster, Brooke, and Zylla, Dylan M

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Women's Health, Social Determinants of Health, Cannabinoid Research, Behavioral and Social Science, Clinical Research, Cancer, 7.1 Individual care needs, Humans, Neoplasms, Female, Male, United States, Middle Aged, Prevalence, Adult, Medical Marijuana, National Cancer Institute (U.S.), Surveys and Questionnaires, Cancer Care Facilities, Aged, Perception, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

BackgroundThe legal climate for cannabis use has dramatically changed with an increasing number of states passing legislation legalizing access for medical and recreational use. Among cancer patients, cannabis is often used to ameliorate adverse effects of cancer treatment. Data are limited on the extent and type of use among cancer patients during treatment and the perceived benefits and harms. This multicenter survey was conducted to assess the use of cannabis among cancer patients residing in states with varied legal access to cannabis.MethodsA total of 12 NCI-Designated Cancer Centers, across states with varied cannabis-access legal status, conducted surveys with a core questionnaire to assess cannabis use among recently diagnosed cancer patients. Data were collected between September 2021 and August 2023 and pooled across 12 cancer centers. Frequencies and 95% confidence intervals for core survey measures were calculated, and weighted estimates are presented for the 10 sites that drew probability samples.ResultsOverall reported cannabis use since cancer diagnosis among survey respondents was 32.9% (weighted), which varied slightly by state legalization status. The most common perceived benefits of use were for pain, sleep, stress and anxiety, and treatment side effects. Reported perceived risks were less common and included inability to drive, difficulty concentrating, lung damage, addiction, and impact on employment. A majority reported feeling comfortable speaking to health-care providers though, overall, only 21.5% reported having done so. Among those who used cannabis since diagnosis, the most common modes were eating in food, smoking, and pills or tinctures, and the most common reasons were for sleep disturbance, followed by pain and stress and anxiety with 60%-68% reporting improved symptoms with use.ConclusionThis geographically diverse survey demonstrates that patients use cannabis regardless of its legal status. Addressing knowledge gaps concerning benefits and harms of cannabis use during cancer treatment is critical to enhance patient-provider communication.

Published
2024

3. Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality

Author

Kempen, John H., Newcomb, Craig W., Washington, Terri L., Foster, C. Stephen, Sobrin, Lucia, Thorne, Jennifer E., Jabs, Douglas A., Suhler, Eric B., Rosenbaum, James T., Sen, H. Nida, Levy-Clarke, Grace A., Nussenblatt, Robert B., Bhatt, Nirali P., Lowder, Careen Y., Goldstein, Debra A., Leiderman, Yannek I., Acharya, Nisha R., Holland, Gary N., Read, Russell W., Dunn, James P., Dreger, Kurt A., Artornsombudh, Pichaporn, Begum, Hosne A., Fitzgerald, Tonetta D., Kothari, Srishti, Payal, Abhishek R., Daniel, Ebenezer, Gangaputra, Sapna S., Kaçmaz, R. Oktay, Liesegang, Teresa L., Pujari, Siddharth S., Khachatryan, Naira, Maghsoudlou, Armin, Suga, Hilkiah K., Pak, Clara M., Helzlsouer, Kathy J., and Buchanich, Jeanine M.

Published
2023
Full Text
View/download PDF

5. A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk

Author

Travis, Ruth C, Perez-Cornago, Aurora, Appleby, Paul N, Albanes, Demetrius, Joshu, Corinne E, Lutsey, Pamela L, Mondul, Alison M, Platz, Elizabeth A, Weinstein, Stephanie J, Layne, Tracy M, Helzlsouer, Kathy J, Visvanathan, Kala, Palli, Domenico, Peeters, Petra H, Bueno-de-Mesquita, Bas, Trichopoulou, Antonia, Gunter, Marc J, Tsilidis, Konstantinos K, Sánchez, Maria-Jose, Olsen, Anja, Brenner, Hermann, Schöttker, Ben, Perna, Laura, Holleczek, Bernd, Knekt, Paul, Rissanen, Harri, Yeap, Bu B, Flicker, Leon, Almeida, Osvaldo P, Wong, Yuen Yee Elizabeth, Chan, June M, Giovannucci, Edward L, Stampfer, Meir J, Ursin, Giske, Gislefoss, Randi E, Bjørge, Tone, Meyer, Haakon E, Blomhoff, Rune, Tsugane, Shoichiro, Sawada, Norie, English, Dallas R, Eyles, Darryl W, Heath, Alicia K, Williamson, Elizabeth J, Manjer, Jonas, Malm, Johan, Almquist, Martin, Marchand, Loic Le, Haiman, Christopher A, Wilkens, Lynne R, Schenk, Jeannette M, Tangen, Cathy M, Black, Amanda, Cook, Michael B, Huang, Wen-Yi, Ziegler, Regina G, Martin, Richard M, Hamdy, Freddie C, Donovan, Jenny L, Neal, David E, Touvier, Mathilde, Hercberg, Serge, Galan, Pilar, Deschasaux, Mélanie, Key, Timothy J, and Allen, Naomi E

Subjects
Clinical Trials and Supportive Activities, Nutrition, Cancer, Prostate Cancer, Urologic Diseases, Prevention, Aging, Clinical Research, Aged, Case-Control Studies, Cross-Sectional Studies, Humans, Male, Middle Aged, Odds Ratio, Prospective Studies, Prostatic Neoplasms, Risk Assessment, Risk Factors, Vitamin D, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

Previous prospective studies assessing the relationship between circulating concentrations of vitamin D and prostate cancer risk have shown inconclusive results, particularly for risk of aggressive disease. In this study, we examine the association between prediagnostic concentrations of 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)2D] and the risk of prostate cancer overall and by tumor characteristics. Principal investigators of 19 prospective studies provided individual participant data on circulating 25(OH)D and 1,25(OH)2D for up to 13,462 men with incident prostate cancer and 20,261 control participants. ORs for prostate cancer by study-specific fifths of season-standardized vitamin D concentration were estimated using multivariable-adjusted conditional logistic regression. 25(OH)D concentration was positively associated with risk for total prostate cancer (multivariable-adjusted OR comparing highest vs. lowest study-specific fifth was 1.22; 95% confidence interval, 1.13-1.31; P trend < 0.001). However, this association varied by disease aggressiveness (P heterogeneity = 0.014); higher circulating 25(OH)D was associated with a higher risk of nonaggressive disease (OR per 80 percentile increase = 1.24, 1.13-1.36) but not with aggressive disease (defined as stage 4, metastases, or prostate cancer death, 0.95, 0.78-1.15). 1,25(OH)2D concentration was not associated with risk for prostate cancer overall or by tumor characteristics. The absence of an association of vitamin D with aggressive disease does not support the hypothesis that vitamin D deficiency increases prostate cancer risk. Rather, the association of high circulating 25(OH)D concentration with a higher risk of nonaggressive prostate cancer may be influenced by detection bias. SIGNIFICANCE: This international collaboration comprises the largest prospective study on blood vitamin D and prostate cancer risk and shows no association with aggressive disease but some evidence of a higher risk of nonaggressive disease.

Published
2019

7. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Author

Travis, Ruth C, Appleby, Paul N, Martin, Richard M, Holly, Jeff MP, Albanes, Demetrius, Black, Amanda, Bueno-de-Mesquita, HB As, Chan, June M, Chen, Chu, Chirlaque, Maria-Dolores, Cook, Michael B, Deschasaux, Mélanie, Donovan, Jenny L, Ferrucci, Luigi, Galan, Pilar, Giles, Graham G, Giovannucci, Edward L, Gunter, Marc J, Habel, Laurel A, Hamdy, Freddie C, Helzlsouer, Kathy J, Hercberg, Serge, Hoover, Robert N, Janssen, Joseph AMJL, Kaaks, Rudolf, Kubo, Tatsuhiko, Le Marchand, Loic, Metter, E Jeffrey, Mikami, Kazuya, Morris, Joan K, Neal, David E, Neuhouser, Marian L, Ozasa, Kotaro, Palli, Domenico, Platz, Elizabeth A, Pollak, Michael, Price, Alison J, Roobol, Monique J, Schaefer, Catherine, Schenk, Jeannette M, Severi, Gianluca, Stampfer, Meir J, Stattin, Pär, Tamakoshi, Akiko, Tangen, Catherine M, Touvier, Mathilde, Wald, Nicholas J, Weiss, Noel S, Ziegler, Regina G, Key, Timothy J, and Allen, Naomi E

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Aging, Prostate Cancer, Cancer, Urologic Diseases, Aged, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Prostatic Neoplasms, Risk Factors, Oncology & Carcinogenesis, Biochemistry and cell biology, Oncology and carcinogenesis
Abstract

The role of insulin-like growth factors (IGF) in prostate cancer development is not fully understood. To investigate the association between circulating concentrations of IGFs (IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3) and prostate cancer risk, we pooled individual participant data from 17 prospective and two cross-sectional studies, including up to 10,554 prostate cancer cases and 13,618 control participants. Conditional logistic regression was used to estimate the ORs for prostate cancer based on the study-specific fifth of each analyte. Overall, IGF-I, IGF-II, IGFBP-2, and IGFBP-3 concentrations were positively associated with prostate cancer risk (Ptrend all ≤ 0.005), and IGFBP-1 was inversely associated weakly with risk (Ptrend = 0.05). However, heterogeneity between the prospective and cross-sectional studies was evident (Pheterogeneity = 0.03), unless the analyses were restricted to prospective studies (with the exception of IGF-II, Pheterogeneity = 0.02). For prospective studies, the OR for men in the highest versus the lowest fifth of each analyte was 1.29 (95% confidence interval, 1.16-1.43) for IGF-I, 0.81 (0.68-0.96) for IGFBP-1, and 1.25 (1.12-1.40) for IGFBP-3. These associations did not differ significantly by time-to-diagnosis or tumor stage or grade. After mutual adjustment for each of the other analytes, only IGF-I remained associated with risk. Our collaborative study represents the largest pooled analysis of the relationship between prostate cancer risk and circulating concentrations of IGF-I, providing strong evidence that IGF-I is highly likely to be involved in prostate cancer development. Cancer Res; 76(8); 2288-300. ©2016 AACR.

Published
2016

8. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies 1–3

Author

Key, Timothy J, Appleby, Paul N, Travis, Ruth C, Albanes, Demetrius, Alberg, Anthony J, Barricarte, Aurelio, Black, Amanda, Boeing, Heiner, Bueno-de-Mesquita, H Bas, Chan, June M, Chen, Chu, Cook, Michael B, Donovan, Jenny L, Galan, Pilar, Gilbert, Rebecca, Giles, Graham G, Giovannucci, Edward, Goodman, Gary E, Goodman, Phyllis J, Gunter, Marc J, Hamdy, Freddie C, Heliövaara, Markku, Helzlsouer, Kathy J, Henderson, Brian E, Hercberg, Serge, Hoffman-Bolton, Judy, Hoover, Robert N, Johansson, Mattias, Khaw, Kay-Tee, King, Irena B, Knekt, Paul, Kolonel, Laurence N, Le Marchand, Loic, Männistö, Satu, Martin, Richard M, Meyer, Haakon E, Mondul, Alison M, Moy, Kristin A, Neal, David E, Neuhouser, Marian L, Palli, Domenico, Platz, Elizabeth A, Pouchieu, Camille, Rissanen, Harri, Schenk, Jeannette M, Severi, Gianluca, Stampfer, Meir J, Tjønneland, Anne, Touvier, Mathilde, Trichopoulou, Antonia, Weinstein, Stephanie J, Ziegler, Regina G, Zhou, Cindy Ke, Allen, Naomi E, Biomarkers, Endogenous Hormones Nutritional, and Group, Prostate Cancer Collaborative

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Prevention, Urologic Diseases, Nutrition, Prostate Cancer, Cancer, Aging, Clinical Research, Adult, Biomarkers, Carotenoids, Case-Control Studies, Cohort Studies, Cross-Sectional Studies, Humans, Lycopene, Male, Meta-Analysis as Topic, Middle Aged, Neoplasm Grading, Neoplasm Staging, Observational Studies as Topic, Prospective Studies, Prostate, Prostatic Neoplasms, Risk Factors, Vitamin A, alpha-Tocopherol, prostate cancer, carotenoids, retinol, tocopherols, vitamin E, vitamin A, pooled analysis, nested case-control study, biomarkers, Endogenous Hormones Nutritional Biomarkers Prostate Cancer Collaborative Group, Engineering, Medical and Health Sciences, Nutrition & Dietetics, Clinical sciences, Nutrition and dietetics
Abstract

BackgroundIndividual studies have suggested that circulating carotenoids, retinol, or tocopherols may be associated with prostate cancer risk, but the studies have not been large enough to provide precise estimates of associations, particularly by stage and grade of disease.ObjectiveThe objective of this study was to conduct a pooled analysis of the associations of the concentrations of 7 carotenoids, retinol, α-tocopherol, and γ-tocopherol with risk of prostate cancer and to describe whether any associations differ by stage or grade of the disease or other factors.DesignPrincipal investigators of prospective studies provided individual participant data for prostate cancer cases and controls. Risk by study-specific fifths of each biomarker was estimated by using multivariable-adjusted conditional logistic regression in matched case-control sets.ResultsData were available for up to 11,239 cases (including 1654 advanced stage and 1741 aggressive) and 18,541 controls from 15 studies. Lycopene was not associated with overall risk of prostate cancer, but there was statistically significant heterogeneity by stage of disease, and the OR for aggressive disease for the highest compared with the lowest fifth of lycopene was 0.65 (95% CI: 0.46, 0.91; P-trend = 0.032). No other carotenoid was significantly associated with overall risk of prostate cancer or with risk of advanced-stage or aggressive disease. For retinol, the OR for the highest compared with the lowest fifth was 1.13 (95% CI: 1.04, 1.22; P-trend = 0.015). For α-tocopherol, the OR for the highest compared with the lowest fifth was 0.86 (95% CI: 0.78, 0.94; P-trend < 0.001), with significant heterogeneity by stage of disease; the OR for aggressive prostate cancer was 0.74 (95% CI: 0.59, 0.92; P-trend = 0.001). γ-Tocopherol was not associated with risk.ConclusionsOverall prostate cancer risk was positively associated with retinol and inversely associated with α-tocopherol, and risk of aggressive prostate cancer was inversely associated with lycopene and α-tocopherol. Whether these associations reflect causal relations is unclear.

Published
2015

9. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

Author

Wolpin, Brian M, Rizzato, Cosmeri, Kraft, Peter, Kooperberg, Charles, Petersen, Gloria M, Wang, Zhaoming, Arslan, Alan A, Beane-Freeman, Laura, Bracci, Paige M, Buring, Julie, Canzian, Federico, Duell, Eric J, Gallinger, Steven, Giles, Graham G, Goodman, Gary E, Goodman, Phyllis J, Jacobs, Eric J, Kamineni, Aruna, Klein, Alison P, Kolonel, Laurence N, Kulke, Matthew H, Li, Donghui, Malats, Núria, Olson, Sara H, Risch, Harvey A, Sesso, Howard D, Visvanathan, Kala, White, Emily, Zheng, Wei, Abnet, Christian C, Albanes, Demetrius, Andreotti, Gabriella, Austin, Melissa A, Barfield, Richard, Basso, Daniela, Berndt, Sonja I, Boutron-Ruault, Marie-Christine, Brotzman, Michelle, Büchler, Markus W, Bueno-de-Mesquita, H Bas, Bugert, Peter, Burdette, Laurie, Campa, Daniele, Caporaso, Neil E, Capurso, Gabriele, Chung, Charles, Cotterchio, Michelle, Costello, Eithne, Elena, Joanne, Funel, Niccola, Gaziano, J Michael, Giese, Nathalia A, Giovannucci, Edward L, Goggins, Michael, Gorman, Megan J, Gross, Myron, Haiman, Christopher A, Hassan, Manal, Helzlsouer, Kathy J, Henderson, Brian E, Holly, Elizabeth A, Hu, Nan, Hunter, David J, Innocenti, Federico, Jenab, Mazda, Kaaks, Rudolf, Key, Timothy J, Khaw, Kay-Tee, Klein, Eric A, Kogevinas, Manolis, Krogh, Vittorio, Kupcinskas, Juozas, Kurtz, Robert C, LaCroix, Andrea, Landi, Maria T, Landi, Stefano, Le Marchand, Loic, Mambrini, Andrea, Mannisto, Satu, Milne, Roger L, Nakamura, Yusuke, Oberg, Ann L, Owzar, Kouros, Patel, Alpa V, Peeters, Petra HM, Peters, Ulrike, Pezzilli, Raffaele, Piepoli, Ada, Porta, Miquel, Real, Francisco X, Riboli, Elio, Rothman, Nathaniel, Scarpa, Aldo, Shu, Xiao-Ou, Silverman, Debra T, Soucek, Pavel, Sund, Malin, Talar-Wojnarowska, Renata, Taylor, Philip R, and Theodoropoulos, George E

Subjects
Cancer, Aged, Case-Control Studies, Female, Genetic Loci, Genetic Predisposition to Disease, Genome-Wide Association Study, Genotype, Humans, Male, Middle Aged, Pancreatic Neoplasms, Polymorphism, Single Nucleotide, White People, Biological Sciences, Medical and Health Sciences, Developmental Biology
Abstract

We performed a multistage genome-wide association study including 7,683 individuals with pancreatic cancer and 14,397 controls of European descent. Four new loci reached genome-wide significance: rs6971499 at 7q32.3 (LINC-PINT, per-allele odds ratio (OR) = 0.79, 95% confidence interval (CI) 0.74-0.84, P = 3.0 × 10(-12)), rs7190458 at 16q23.1 (BCAR1/CTRB1/CTRB2, OR = 1.46, 95% CI 1.30-1.65, P = 1.1 × 10(-10)), rs9581943 at 13q12.2 (PDX1, OR = 1.15, 95% CI 1.10-1.20, P = 2.4 × 10(-9)) and rs16986825 at 22q12.1 (ZNRF3, OR = 1.18, 95% CI 1.12-1.25, P = 1.2 × 10(-8)). We identified an independent signal in exon 2 of TERT at the established region 5p15.33 (rs2736098, OR = 0.80, 95% CI 0.76-0.85, P = 9.8 × 10(-14)). We also identified a locus at 8q24.21 (rs1561927, P = 1.3 × 10(-7)) that approached genome-wide significance located 455 kb telomeric of PVT1. Our study identified multiple new susceptibility alleles for pancreatic cancer that are worthy of follow-up studies.

Published
2014

13. Anthropometric Measures, Body Mass Index, and Pancreatic Cancer: A Pooled Analysis From the Pancreatic Cancer Cohort Consortium (PanScan)

Author

Arslan, Alan A, Helzlsouer, Kathy J, Kooperberg, Charles, Shu, Xiao-Ou, Steplowski, Emily, Bueno-de-Mesquita, H Bas, Fuchs, Charles S, Gross, Myron D, Jacobs, Eric J, Lacroix, Andrea Z, Petersen, Gloria M, Stolzenberg-Solomon, Rachael Z, Zheng, Wei, Albanes, Demetrius, Amundadottir, Laufey, Bamlet, William R, Barricarte, Aurelio, Bingham, Sheila A, Boeing, Heiner, Boutron-Ruault, Marie-Christine, Buring, Julie E, Chanock, Stephen J, Clipp, Sandra, Gaziano, J Michael, Giovannucci, Edward L, Hankinson, Susan E, Hartge, Patricia, Hoover, Robert N, Hunter, David J, Hutchinson, Amy, Jacobs, Kevin B, Kraft, Peter, Lynch, Shannon M, Manjer, Jonas, Manson, Joann E, McTiernan, Anne, McWilliams, Robert R, Mendelsohn, Julie B, Michaud, Dominique S, Palli, Domenico, Rohan, Thomas E, Slimani, Nadia, Thomas, Gilles, Tjønneland, Anne, Tobias, Geoffrey S, Trichopoulos, Dimitrios, Virtamo, Jarmo, Wolpin, Brian M, Yu, Kai, Zeleniuch-Jacquotte, Anne, and Patel, Alpa V

Subjects
Obesity, Cancer, Clinical Research, Nutrition, Prevention, Pancreatic Cancer, Rare Diseases, Digestive Diseases, Adult, Aged, Aged, 80 and over, Body Mass Index, Case-Control Studies, Female, Humans, Logistic Models, Male, Middle Aged, Overweight, Pancreatic Neoplasms, Risk Factors, Sex Distribution, United States, Waist Circumference, Pancreatic Cancer Cohort Consortium, Clinical Sciences, Opthalmology and Optometry, Public Health and Health Services
Abstract

BackgroundObesity has been proposed as a risk factor for pancreatic cancer.MethodsPooled data were analyzed from the National Cancer Institute Pancreatic Cancer Cohort Consortium (PanScan) to study the association between prediagnostic anthropometric measures and risk of pancreatic cancer. PanScan applied a nested case-control study design and included 2170 cases and 2209 control subjects. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression for cohort-specific quartiles of body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]), weight, height, waist circumference, and waist to hip ratio as well as conventional BMI categories (underweight, or = 35.0). Models were adjusted for potential confounders.ResultsIn all of the participants, a positive association between increasing BMI and risk of pancreatic cancer was observed (adjusted OR for the highest vs lowest BMI quartile, 1.33; 95% CI, 1.12-1.58; P(trend) < .001). In men, the adjusted OR for pancreatic cancer for the highest vs lowest quartile of BMI was 1.33 (95% CI, 1.04-1.69; P(trend) < .03), and in women it was 1.34 (95% CI, 1.05-1.70; P(trend) = .01). Increased waist to hip ratio was associated with increased risk of pancreatic cancer in women (adjusted OR for the highest vs lowest quartile, 1.87; 95% CI, 1.31-2.69; P(trend) = .003) but less so in men.ConclusionsThese findings provide strong support for a positive association between BMI and pancreatic cancer risk. In addition, centralized fat distribution may increase pancreatic cancer risk, especially in women.

Published
2010

14. Use of immunosuppression and subsequent cancer incidence: cohort study

Author

Buchanich, Jeanine M, primary, Newcomb, Craig W, additional, Washington, Terri L, additional, Foster, Charles Stephen, additional, Sobrin, Lucia, additional, Thorne, Jennifer E, additional, Jabs, Douglas Alan, additional, Suhler, Eric B, additional, Rosenbaum, James T, additional, Sen, Hatice Nida, additional, Levy-Clarke, Grace A, additional, Nussenblatt, Robert B, additional, Bhatt, Nirali P, additional, Lowder, Careen Y, additional, Goldstein, Debra A, additional, Leiderman, Yannek I, additional, Acharya, Nisha R, additional, Holland, Gary N, additional, Read, Russell W, additional, Dunn, James P, additional, Dreger, Kurt A, additional, Artornsombudh, Pichaporn, additional, Begum, Hosne A, additional, Fitzgerald, Tonetta D, additional, Kothari, Srishti, additional, Payal, Abhishek R, additional, Daniel, Ebenezer, additional, Gangaputra, Sapna S, additional, Kaçmaz, Roje Oktay, additional, Liesegang, Teresa L, additional, Pujari, Siddharth S, additional, Khachatryan, Naira, additional, Maghsoudlou, Armin, additional, Suga, Hilkiah K, additional, Pak, Clara M, additional, Helzlsouer, Kathy J, additional, and Kempen, John H, additional

Published
2023
Full Text
View/download PDF

15. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women

Author

Jung, Seungyoun, Allen, Naomi, Arslan, Alan A., Baglietto, Laura, Brinton, Louise A., Egleston, Brian L., Falk, Roni, Fortner, Renée T., Helzlsouer, Kathy J., Idahl, Annika, Kaaks, Rudolph, Lundin, Eva, Merritt, Melissa, Onland-Moret, Charlotte, Rinaldi, Sabina, Sánchez, María-José, Sieri, Sabina, Schock, Helena, Shu, Xiao-Ou, Sluss, Patrick M., Staats, Paul N., Travis, Ruth C., Tjønneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley, Visvanathan, Kala, Krogh, Vittorio, Weiderpass, Elisabete, Zeleniuch-Jacquotte, Anne, Zheng, Wei, and Dorgan, Joanne F.

Published
2017
Full Text
View/download PDF

18. Remission of Intermediate Uveitis: Incidence and Predictive Factors

Author

Kempen, John H., Joffe, Marshall M., Dreger, Kurt A., Fitzgerald, Tonetta D., Newcomb, Craig W., Pistilli, Maxwell, Kothari, Srishti, Khacharyan, Naira, Artornsombudh, Pichaporn, Hanish, Asaf, Payal, Abhishek, Gangaputra, Sapna S., Thorne, Jennifer E., Begum, Hosne, Daniel, Ebenezer, Dunn, James P., Jabs, Douglas A., Helzlsouer, Kathy J., Foster, C. Stephen, Kaçmaz, R. Oktay, Pujari, Siddharth S., Sen, H. Nida, Nussenblatt, Robert B., Levy-Clarke, Grace A., Suhler, Eric B., Rosenbaum, James T., Liesegang, Teresa, Buchanich, Jeanine, Washington, Terri L., Gewaily, Dina Y., and Liesegang, Teresa L.

Published
2016
Full Text
View/download PDF

20. Supplementary Materials and Methods from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Author

Travis, Ruth C., primary, Appleby, Paul N., primary, Martin, Richard M., primary, Holly, Jeff M.P., primary, Albanes, Demetrius, primary, Black, Amanda, primary, Bueno-de-Mesquita, H. Bas, primary, Chan, June M., primary, Chen, Chu, primary, Chirlaque, Maria-Dolores, primary, Cook, Michael B., primary, Deschasaux, Mélanie, primary, Donovan, Jenny L., primary, Ferrucci, Luigi, primary, Galan, Pilar, primary, Giles, Graham G., primary, Giovannucci, Edward L., primary, Gunter, Marc J., primary, Habel, Laurel A., primary, Hamdy, Freddie C., primary, Helzlsouer, Kathy J., primary, Hercberg, Serge, primary, Hoover, Robert N., primary, Janssen, Joseph A.M.J.L., primary, Kaaks, Rudolf, primary, Kubo, Tatsuhiko, primary, Le Marchand, Loic, primary, Metter, E. Jeffrey, primary, Mikami, Kazuya, primary, Morris, Joan K., primary, Neal, David E., primary, Neuhouser, Marian L., primary, Ozasa, Kotaro, primary, Palli, Domenico, primary, Platz, Elizabeth A., primary, Pollak, Michael N., primary, Price, Alison J., primary, Roobol, Monique J., primary, Schaefer, Catherine, primary, Schenk, Jeannette M., primary, Severi, Gianluca, primary, Stampfer, Meir J., primary, Stattin, Pär, primary, Tamakoshi, Akiko, primary, Tangen, Catherine M., primary, Touvier, Mathilde, primary, Wald, Nicholas J., primary, Weiss, Noel S., primary, Ziegler, Regina G., primary, Key, Timothy J., primary, and Allen, Naomi E., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure Legends from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Author

Travis, Ruth C., primary, Appleby, Paul N., primary, Martin, Richard M., primary, Holly, Jeff M.P., primary, Albanes, Demetrius, primary, Black, Amanda, primary, Bueno-de-Mesquita, H. Bas, primary, Chan, June M., primary, Chen, Chu, primary, Chirlaque, Maria-Dolores, primary, Cook, Michael B., primary, Deschasaux, Mélanie, primary, Donovan, Jenny L., primary, Ferrucci, Luigi, primary, Galan, Pilar, primary, Giles, Graham G., primary, Giovannucci, Edward L., primary, Gunter, Marc J., primary, Habel, Laurel A., primary, Hamdy, Freddie C., primary, Helzlsouer, Kathy J., primary, Hercberg, Serge, primary, Hoover, Robert N., primary, Janssen, Joseph A.M.J.L., primary, Kaaks, Rudolf, primary, Kubo, Tatsuhiko, primary, Le Marchand, Loic, primary, Metter, E. Jeffrey, primary, Mikami, Kazuya, primary, Morris, Joan K., primary, Neal, David E., primary, Neuhouser, Marian L., primary, Ozasa, Kotaro, primary, Palli, Domenico, primary, Platz, Elizabeth A., primary, Pollak, Michael N., primary, Price, Alison J., primary, Roobol, Monique J., primary, Schaefer, Catherine, primary, Schenk, Jeannette M., primary, Severi, Gianluca, primary, Stampfer, Meir J., primary, Stattin, Pär, primary, Tamakoshi, Akiko, primary, Tangen, Catherine M., primary, Touvier, Mathilde, primary, Wald, Nicholas J., primary, Weiss, Noel S., primary, Ziegler, Regina G., primary, Key, Timothy J., primary, and Allen, Naomi E., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Tables 1 through 8 and Supplementary Figures 1 through 15 from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Author

Travis, Ruth C., primary, Appleby, Paul N., primary, Martin, Richard M., primary, Holly, Jeff M.P., primary, Albanes, Demetrius, primary, Black, Amanda, primary, Bueno-de-Mesquita, H. Bas, primary, Chan, June M., primary, Chen, Chu, primary, Chirlaque, Maria-Dolores, primary, Cook, Michael B., primary, Deschasaux, Mélanie, primary, Donovan, Jenny L., primary, Ferrucci, Luigi, primary, Galan, Pilar, primary, Giles, Graham G., primary, Giovannucci, Edward L., primary, Gunter, Marc J., primary, Habel, Laurel A., primary, Hamdy, Freddie C., primary, Helzlsouer, Kathy J., primary, Hercberg, Serge, primary, Hoover, Robert N., primary, Janssen, Joseph A.M.J.L., primary, Kaaks, Rudolf, primary, Kubo, Tatsuhiko, primary, Le Marchand, Loic, primary, Metter, E. Jeffrey, primary, Mikami, Kazuya, primary, Morris, Joan K., primary, Neal, David E., primary, Neuhouser, Marian L., primary, Ozasa, Kotaro, primary, Palli, Domenico, primary, Platz, Elizabeth A., primary, Pollak, Michael N., primary, Price, Alison J., primary, Roobol, Monique J., primary, Schaefer, Catherine, primary, Schenk, Jeannette M., primary, Severi, Gianluca, primary, Stampfer, Meir J., primary, Stattin, Pär, primary, Tamakoshi, Akiko, primary, Tangen, Catherine M., primary, Touvier, Mathilde, primary, Wald, Nicholas J., primary, Weiss, Noel S., primary, Ziegler, Regina G., primary, Key, Timothy J., primary, and Allen, Naomi E., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Data from A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk

Author

Travis, Ruth C., primary, Perez-Cornago, Aurora, primary, Appleby, Paul N., primary, Albanes, Demetrius, primary, Joshu, Corinne E., primary, Lutsey, Pamela L., primary, Mondul, Alison M., primary, Platz, Elizabeth A., primary, Weinstein, Stephanie J., primary, Layne, Tracy M., primary, Helzlsouer, Kathy J., primary, Visvanathan, Kala, primary, Palli, Domenico, primary, Peeters, Petra H., primary, Bueno-de-Mesquita, Bas, primary, Trichopoulou, Antonia, primary, Gunter, Marc J., primary, Tsilidis, Konstantinos K., primary, Sánchez, Maria-Jose, primary, Olsen, Anja, primary, Brenner, Hermann, primary, Schöttker, Ben, primary, Perna, Laura, primary, Holleczek, Bernd, primary, Knekt, Paul, primary, Rissanen, Harri, primary, Yeap, Bu B., primary, Flicker, Leon, primary, Almeida, Osvaldo P., primary, Wong, Yuen Yee Elizabeth, primary, Chan, June M., primary, Giovannucci, Edward L., primary, Stampfer, Meir J., primary, Ursin, Giske, primary, Gislefoss, Randi E., primary, Bjørge, Tone, primary, Meyer, Haakon E., primary, Blomhoff, Rune, primary, Tsugane, Shoichiro, primary, Sawada, Norie, primary, English, Dallas R., primary, Eyles, Darryl W., primary, Heath, Alicia K., primary, Williamson, Elizabeth J., primary, Manjer, Jonas, primary, Malm, Johan, primary, Almquist, Martin, primary, Marchand, Loic Le, primary, Haiman, Christopher A., primary, Wilkens, Lynne R., primary, Schenk, Jeannette M., primary, Tangen, Cathy M., primary, Black, Amanda, primary, Cook, Michael B., primary, Huang, Wen-Yi, primary, Ziegler, Regina G., primary, Martin, Richard M., primary, Hamdy, Freddie C., primary, Donovan, Jenny L., primary, Neal, David E., primary, Touvier, Mathilde, primary, Hercberg, Serge, primary, Galan, Pilar, primary, Deschasaux, Mélanie, primary, Key, Timothy J., primary, and Allen, Naomi E., primary

Published
2023
Full Text
View/download PDF

24. Data from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

Author

Travis, Ruth C., primary, Appleby, Paul N., primary, Martin, Richard M., primary, Holly, Jeff M.P., primary, Albanes, Demetrius, primary, Black, Amanda, primary, Bueno-de-Mesquita, H. Bas, primary, Chan, June M., primary, Chen, Chu, primary, Chirlaque, Maria-Dolores, primary, Cook, Michael B., primary, Deschasaux, Mélanie, primary, Donovan, Jenny L., primary, Ferrucci, Luigi, primary, Galan, Pilar, primary, Giles, Graham G., primary, Giovannucci, Edward L., primary, Gunter, Marc J., primary, Habel, Laurel A., primary, Hamdy, Freddie C., primary, Helzlsouer, Kathy J., primary, Hercberg, Serge, primary, Hoover, Robert N., primary, Janssen, Joseph A.M.J.L., primary, Kaaks, Rudolf, primary, Kubo, Tatsuhiko, primary, Le Marchand, Loic, primary, Metter, E. Jeffrey, primary, Mikami, Kazuya, primary, Morris, Joan K., primary, Neal, David E., primary, Neuhouser, Marian L., primary, Ozasa, Kotaro, primary, Palli, Domenico, primary, Platz, Elizabeth A., primary, Pollak, Michael N., primary, Price, Alison J., primary, Roobol, Monique J., primary, Schaefer, Catherine, primary, Schenk, Jeannette M., primary, Severi, Gianluca, primary, Stampfer, Meir J., primary, Stattin, Pär, primary, Tamakoshi, Akiko, primary, Tangen, Catherine M., primary, Touvier, Mathilde, primary, Wald, Nicholas J., primary, Weiss, Noel S., primary, Ziegler, Regina G., primary, Key, Timothy J., primary, and Allen, Naomi E., primary

Published
2023
Full Text
View/download PDF

25. Data from A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk

Author

Travis, Ruth C., primary, Perez-Cornago, Aurora, primary, Appleby, Paul N., primary, Albanes, Demetrius, primary, Joshu, Corinne E., primary, Lutsey, Pamela L., primary, Mondul, Alison M., primary, Platz, Elizabeth A., primary, Weinstein, Stephanie J., primary, Layne, Tracy M., primary, Helzlsouer, Kathy J., primary, Visvanathan, Kala, primary, Palli, Domenico, primary, Peeters, Petra H., primary, Bueno-de-Mesquita, Bas, primary, Trichopoulou, Antonia, primary, Gunter, Marc J., primary, Tsilidis, Konstantinos K., primary, Sánchez, Maria-Jose, primary, Olsen, Anja, primary, Brenner, Hermann, primary, Schöttker, Ben, primary, Perna, Laura, primary, Holleczek, Bernd, primary, Knekt, Paul, primary, Rissanen, Harri, primary, Yeap, Bu B., primary, Flicker, Leon, primary, Almeida, Osvaldo P., primary, Wong, Yuen Yee Elizabeth, primary, Chan, June M., primary, Giovannucci, Edward L., primary, Stampfer, Meir J., primary, Ursin, Giske, primary, Gislefoss, Randi E., primary, Bjørge, Tone, primary, Meyer, Haakon E., primary, Blomhoff, Rune, primary, Tsugane, Shoichiro, primary, Sawada, Norie, primary, English, Dallas R., primary, Eyles, Darryl W., primary, Heath, Alicia K., primary, Williamson, Elizabeth J., primary, Manjer, Jonas, primary, Malm, Johan, primary, Almquist, Martin, primary, Marchand, Loic Le, primary, Haiman, Christopher A., primary, Wilkens, Lynne R., primary, Schenk, Jeannette M., primary, Tangen, Cathy M., primary, Black, Amanda, primary, Cook, Michael B., primary, Huang, Wen-Yi, primary, Ziegler, Regina G., primary, Martin, Richard M., primary, Hamdy, Freddie C., primary, Donovan, Jenny L., primary, Neal, David E., primary, Touvier, Mathilde, primary, Hercberg, Serge, primary, Galan, Pilar, primary, Deschasaux, Mélanie, primary, Key, Timothy J., primary, and Allen, Naomi E., primary

Published
2023
Full Text
View/download PDF

30. Anti‐Müllerian hormone and risk of ovarian cancer in nine cohorts

Author

Jung, Seungyoun, Allen, Naomi, Arslan, Alan A., Baglietto, Laura, Barricarte, Aurelio, Brinton, Louise A., Egleston, Brian L., Falk, Roni T., Fortner, Renée T., Helzlsouer, Kathy J., Gao, Yutang, Idahl, Annika, Kaaks, Rudolph, Krogh, Vittorio, Merritt, Melissa A., Lundin, Eva, Onland‐Moret, N. Charlotte, Rinaldi, Sabina, Schock, Helena, Shu, Xiao‐Ou, Sluss, Patrick M., Staats, Paul N., Sacerdote, Carlotta, Travis, Ruth C., Tjønneland, Anne, Trichopoulou, Antonia, Tworoger, Shelley S., Visvanathan, Kala, Weiderpass, Elisabete, Zeleniuch‐Jacquotte, Anne, and Dorgan, Joanne F.

Published
2018
Full Text
View/download PDF

34. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies

Author

Zhang, Xuehong, Spiegelman, Donna, Baglietto, Laura, Bernstein, Leslie, Boggs, Deborah A, van den Brandt, Piet A, Buring, Julie E, Gapstur, Susan M, Giles, Graham G, Giovannucci, Edward, Goodman, Gary, Hankinson, Susan E, Helzlsouer, Kathy J, Horn-Ross, Pamela L, Inoue, Manami, Jung, Seungyoun, Khudyakov, Polyna, Larsson, Susanna C, Lof, Marie, McCullough, Marjorie L, Miller, Anthony B, Neuhouser, Marian L, Palmer, Julie R, Park, Yikyung, Robien, Kim, Rohan, Thomas E, Ross, Julie A, Schouten, Leo J, Shikany, James M, Tsugane, Shoichiro, Visvanathan, Kala, Weiderpass, Elisabete, Wolk, Alicja, Willett, Walter C, Zhang, Shumin M, Ziegler, Regina G, and Smith-Warner, Stephanie A

Published
2012
Full Text
View/download PDF

45. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies1-3

Author

Key, Timothy J, Appleby, Paul N, Travis, Ruth C, Albanes, Demetrius, Alberg, Anthony J, Barricarte, Aurelio, Black, Amanda, Boeing, Heiner, Bueno-de-Mesquita, H Bas, Chan, June M, Chen, Chu, Cook, Michael B, Donovan, Jenny L, Galan, Pilar, Gilbert, Rebecca, Giles, Graham G, Giovannucci, Edward, Goodman, Gary E, Goodman, Phyllis J, Gunter, Marc J, Hamdy, Freddie C, Heliövaara, Markku, Helzlsouer, Kathy J, Henderson, Brian E, Hercberg, Serge, Hoffman-Bolton, Judy, Hoover, Robert N, Johansson, Mattias, Khaw, Kay-Tee, King, Irena B, Knekt, Paul, Kolonel, Laurence N, Le Marchand, Loic, Männistö, Satu, Martin, Richard M, Meyer, Haakon E, Mondul, Alison M, Moy, Kristin A, Neal, David E, Neuhouser, Marian L, Palli, Domenico, Platz, Elizabeth A, Pouchieu, Camille, Rissanen, Harri, Schenk, Jeannette M, Severi, Gianluca, Stampfer, Meir J, Tjønneland, Anne, Touvier, Mathilde, Trichopoulou, Antonia, Weinstein, Stephanie J, Ziegler, Regina G, Zhou, Cindy Ke, Allen, Naomi E, and Biomarkers, Nutritional

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results